CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo

被引:32
作者
Alajati, Abdullah [1 ,2 ]
D'Ambrosio, Mariantonietta [1 ,2 ,3 ]
Troiani, Martina [1 ,2 ]
Mosole, Simone [1 ,2 ]
Pellegrini, Laura [1 ,2 ]
Chen, Jingjing [1 ,2 ,3 ]
Revandkar, Ajinkya [1 ,2 ,3 ]
Bolis, Marco [1 ,2 ]
Theurillat, Jean-Philippe [1 ,2 ]
Guccini, Ilaria [1 ,2 ]
Losa, Marco [1 ,2 ]
Calcinotto, Arianna [1 ,2 ]
De Bernardis, Gaston [1 ,2 ]
Pasquini, Emiliano [1 ,2 ]
D'Antuono, Rocco [4 ]
Sharp, Adam [5 ]
Figueiredo, Ines [5 ,6 ]
Rodrigues, Daniel Nava [5 ,6 ]
Welti, Jonathan [5 ,6 ]
Gil, Veronica [5 ,6 ]
Yuan, Wei [5 ,6 ]
Vlajnic, Tatjana [7 ]
Bubendorf, Lukas [7 ]
Chiorino, Giovanna [8 ]
Gnetti, Letizia [9 ]
Torrano, Veronica [10 ,11 ,12 ]
Carracedo, Arkaitz [10 ,11 ,12 ,13 ]
Camplese, Laura [14 ]
Hirabayashi, Susumu [14 ]
Canato, Elena [15 ]
Pasut, Gianfranco [15 ]
Montopoli, Monica [15 ]
Ruschoff, Jan Hendrik [16 ]
Wild, Peter [16 ]
Moch, Holger [16 ]
De Bono, Johann [5 ,6 ]
Alimonti, Andrea [1 ,2 ,3 ,17 ,18 ]
机构
[1] Oncol Inst Southern Switzerland IOSI, Inst Oncol Res IOR, Bellinzona, Switzerland
[2] Univ Svizzera Italiana, Lugano, Switzerland
[3] Univ Lausanne UNIL, Fac Biol & Med, Lausanne, Switzerland
[4] Inst Res Biomed IRB, Bellinzona, Switzerland
[5] Inst Canc Res, Div Clin Studies, London, England
[6] Royal Marsden NHS Fdn Trust, London, England
[7] Univ Hosp Basel, Inst Pathol, Basel, Switzerland
[8] Fdn Edo & Elvo Tempia, Via Malta, Biella, Italy
[9] Univ Hosp Parma, Pathol Unit, Parma, Italy
[10] Basque Res & Technol Alliance BRTA, Ctr Cooperat Res Biosci CIC BioGUNE, Derio, Spain
[11] Univ Basque Country UPV EHU, Biochem & Mol Biol Dept, Bilbao, Spain
[12] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
[13] Ikerbasque Basque Fdn Sci, Bilbao, Spain
[14] Imperial Coll London, MRC London Inst Med Sci LMS, London, England
[15] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy
[16] Univ Hosp Zurich, Inst Pathol & Mol Pathol, Zurich, Switzerland
[17] Univ Padua, Dept Med, Padua, Italy
[18] Eidgenoss Tech Hsch Zurich ETH, Dept Hlth Sci & Technol, Zurich, Switzerland
基金
欧洲研究理事会; 瑞士国家科学基金会; 英国医学研究理事会; 欧盟地平线“2020”;
关键词
DOMAIN-CONTAINING PROTEIN-1; SURFACE GLYCOPROTEIN CDCP1; PTEN LOSS; RECEPTOR; MECHANISMS; EXPRESSION; METASTASIS; RESISTANCE; GROWTH; SRC;
D O I
10.1172/JCI131133
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The mechanisms by which prostate cancer shifts from an indolent castration-sensitive phenotype to lethal castration-resistant prostate cancer (CRPC) are poorly understood. Identification of clinically relevant genetic alterations leading to CRPC may reveal potential vulnerabilities for cancer therapy. Here we find that CUB domain-containing protein 1 (CDCP1), a transmembrane protein that acts as a substrate for SRC family kinases (SFKs), is overexpressed in a subset of CRPC. Notably, CDCP1 cooperates with the loss of the tumor suppressor gene PTEN to promote the emergence of metastatic prostate cancer. Mechanistically, we find that androgens suppress CDCP1 expression and that androgen deprivation in combination with loss of PTEN promotes the upregulation of CDCP1 and the subsequent activation of the SRC/MAPK pathway. Moreover, we demonstrate that anti-CDCP1 immunoliposomes (anti-CDCP1 ILs) loaded with chemotherapy suppress prostate cancer growth when administered in combination with enzalutamide. Thus, our study identifies CDCP1 as a powerful driver of prostate cancer progression and uncovers different potential therapeutic strategies for the treatment of metastatic prostate tumors.
引用
收藏
页码:2435 / 2450
页数:16
相关论文
共 57 条
[1]   Subtle variations in Pten dose determine cancer susceptibility [J].
Alimonti, Andrea ;
Carracedo, Arkaitz ;
Clohessy, John G. ;
Trotman, Lloyd C. ;
Nardella, Caterina ;
Egia, Ainara ;
Salmena, Leonardo ;
Sampieri, Katia ;
Haveman, William J. ;
Brogi, Edi ;
Richardson, Andrea L. ;
Zhang, Jiangwen ;
Pandolfi, Pier Paolo .
NATURE GENETICS, 2010, 42 (05) :454-U136
[2]   A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis [J].
Alimonti, Andrea ;
Nardella, Caterina ;
Chen, Zhenbang ;
Clohessy, John G. ;
Carracedo, Arkaitz ;
Trotman, Lloyd C. ;
Cheng, Ke ;
Varmeh, Shohreh ;
Kozma, Sara C. ;
Thomas, George ;
Rosivatz, Erika ;
Woscholski, Rudiger ;
Cognetti, Francesco ;
Scher, Howard I. ;
Pandolfi, Pier Paolo .
JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (03) :681-693
[3]   MYC BUT NOT FOS RESCUE OF PDGF SIGNALING BLOCK CAUSED BY KINASE INACTIVE SRC [J].
BARONE, MV ;
COURTNEIDGE, S .
NATURE, 1995, 378 (6556) :509-512
[4]   Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells [J].
Beard, C ;
Hochedlinger, K ;
Plath, K ;
Wutz, A ;
Jaenisch, R .
GENESIS, 2006, 44 (01) :23-28
[5]   Adhesion signaling by a novel mitotic substrate of src kinases [J].
Bhatt, AS ;
Erdjument-Bromage, H ;
Tempst, P ;
Craik, CS ;
Moasser, MM .
ONCOGENE, 2005, 24 (34) :5333-5343
[6]   Adhesion or plasmin regulates tyrosine phosphorylation of a novel membrane glycoprotein p80/gp140/CUB domain-containing protein 1 in epithelia [J].
Brown, TA ;
Yang, TM ;
Zaitsevskaia, T ;
Xia, YP ;
Dunn, CA ;
Sigle, RO ;
Knudsen, B ;
Carter, WG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (15) :14772-14783
[7]   Using Drosophila melanogaster to map human cancer pathways [J].
Brumby, AM ;
Richardson, HE .
NATURE REVIEWS CANCER, 2005, 5 (08) :626-639
[8]   Src tyrosine kinase signaling antagonizes nuclear localization of FOXO and inhibits its transcription factor activity [J].
Buelow, Margret H. ;
Buelow, Torsten R. ;
Hoch, Michael ;
Pankratz, Michael J. ;
Juenger, Martin A. .
SCIENTIFIC REPORTS, 2014, 4
[9]   Androgen Deprivation-Induced Senescence Promotes Outgrowth of Androgen-Refractory Prostate Cancer Cells [J].
Burton, Dominick G. A. ;
Giribaldi, Maria G. ;
Munoz, Anisleidys ;
Halvorsen, Katherine ;
Patel, Asmita ;
Jorda, Merce ;
Perez-Stable, Carlos ;
Rai, Priyamvada .
PLOS ONE, 2013, 8 (06)
[10]   Aging and cancer: The double-edged sword of replicative senescence [J].
Campisi, J .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (04) :482-488